Phase 3 Trials – Discover Pharma

Welcome to Discover Pharma! Today is : January 17, 2026

Phase 3 Trials

Biomanufacturing,Clinical Trials,European biotech,Pharmaceuticals and therapeutics,Regulatory Affairs,Supply Chain & Logistics
Klifo receives regulatory approval for new clinical trial supply facility in Copenhagen
KLIFO, Europe’s largest independent provider of clinical trial supply (CTS) [...]

October 9, 2025
Clinical Development,Clinical studies,Data Management,Technology and platforms
REDCap Cloud 2.0 launched to harmonize clinical trial and real-world data for AI-driven research
REDCap Cloud has launched version 2.0, a clinical trial data [...]

September 24, 2025
Clinical Development,Clinical Trials,Dermatology,Pharmaceuticals and therapeutics
Icotrokinra shows superiority to deucravacitinib in first head-to-head Phase 3 trials for plaque psoriasis
Johnson & Johnson has reported new data from the Phase [...]

September 23, 2025
Clinical Development,Clinical Trials,Data Management,Patient Centricity,Real world evidence,Research & Development
TransCelerate and Tufts study finds nearly one-third of clinical trial data adds limited value
A new collaborative study from TransCelerate BioPharma and the Tufts [...]

September 22, 2025
Drug Development,Patient Centricity,Rare Diseases,Regulatory Affairs
MHRA approves Biogen’s tofersen for ultra-rare genetic form of motor neurone disease
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has [...]

July 28, 2025
Clinical Development,Clinical Trials,Patient Centricity
Phesi CEO warns of looming Phase 3 trial failures as sponsors overlook real-world data and overcrowd sites
New analysis reveals billions risked on overly complex trials that [...]

July 10, 2025
Clinical Trials
Oculis completes enrollment in DIAMOND Phase 3 trials of OCS-01 for diabetic macular edema
June 4, 2025

main menu

get connected

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK